Condition (MeSH)
Stenosis, Pulmonary Artery
ClinicalTrials.gov lists 11 trials for Stenosis, Pulmonary Artery or a narrower condition beneath it. Renata Medical has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
11 of the 11 trials are tagged with Stenosis, Pulmonary Artery itself; the rest are tagged with a narrower condition beneath it.
When did Stenosis, Pulmonary Artery trials start? (9)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Not applicable
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 1 |
| 2023 | 1 |
| 2022 | 1 |
| 2021 | 2 |
| 2018 | 1 |
| 2016 | 1 |
| 2015 | 1 |
| 2003 | 1 |
No forecast is made for this condition: it averages 0.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 11 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Stenosis, Pulmonary Artery trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Not applicable | 7 |
| Observational | 4 |
How many Stenosis, Pulmonary Artery trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 2 |
| Active, not recruiting | 2 |
| Completed | 4 |
| Unknown status | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Stenosis, Pulmonary Artery trials? (5)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Renata Medical | 2 |
| Bentley InnoMed GmbH | 1 |
| Biotyx Medical (Shenzhen) Co., Ltd. | 1 |
| Cordis US Corp. | 1 |
| PediaStent LLC | 1 |
Interventions as named in the registry (1)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Induction of anesthesia | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Stenosis, Pulmonary Artery? (3)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Multicenter Pivotal Trial of the Minima Stent for Vascular Stenosis in Infants and Young Children. | Circulation. Cardiovascular interventions | 2025 | Yes |
| Exercise feature and predictor of prognosis in patients with pulmonary artery stenosis-associated pulmonary hypertension. | ESC heart failure | 2022 | Yes |
| The effects of percutaneous branch pulmonary artery interventions in biventricular congenital heart disease: study protocol for a randomized controlled Dutch multicenter interventional trial. | Trials | 2024 | No |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.